Figure 1.

Genetic mutations in galectin-9: (a) an overview of the mutations in galectin-9 in the samples from patients with haematopoietic and lymphoid malignancies, according to the COSMIC database. (b) The substitution mutations of galectin-9 in the haematopoietic and lymphoid cancer samples, according to the COSMIC database. (c) Schematic representation of galectin-9, indicating the location of the mutations identified by targeted deep sequencing in patients with diffuse large B cell lymphoma (DLBCL).